NEW YORK, March 2, 2023 /PRNewswire/ — The biologics CDMO market is estimated to accelerate at a CAGR of 13.97% and register an incremental growth of USD 13.26 billion during the forecast period. The strong research and development pipeline of biologics therapeutics is driving the market…